NIVABUPA - Investment Analysis: Buy Signal or Bull Trap?
Back to ListInvestment Rating: 2.9
| Stock Code | NIVABUPA | Market Cap | 14,480 Cr. | Current Price | 78.3 ₹ | High / Low | 95.2 ₹ |
| Book Value | 20.6 ₹ | Dividend Yield | 0.00 % | ROCE | 7.45 % | ROE | 8.18 % |
| Face Value | 10.0 ₹ | DMA 50 | 75.6 ₹ | DMA 200 | 76.9 ₹ | Chg in FII Hold | 0.29 % |
| Chg in DII Hold | 0.45 % | PAT Qtr | -87.6 Cr. | PAT Prev Qtr | -35.3 Cr. | RSI | 57.1 |
| MACD | 1.40 | Volume | 59,47,874 | Avg Vol 1Wk | 23,88,446 | Low price | 67.5 ₹ |
| High price | 95.2 ₹ | Debt to equity | 0.07 | 52w Index | 38.9 % | Qtr Profit Var | -762 % |
| EPS | -0.03 ₹ | Industry PE | 32.0 |
📊 NIVABUPA shows weak fundamentals with low ROE (8.18%) and ROCE (7.45%). The company is loss-making (PAT -87.6 Cr vs -35.3 Cr) and EPS is negative (-0.03 ₹). Dividend yield is 0%, offering no income support. Debt-to-equity (0.07) is low, which is positive, but profitability remains a major concern. Valuation cannot be assessed meaningfully due to losses, making long-term investment unattractive at present. Technicals show neutral momentum (RSI 57.1, MACD 1.40) with price hovering around DMA levels (50 DMA: 75.6 ₹, 200 DMA: 76.9 ₹). The stock is far below its 52-week high (Index 38.9%), reflecting weakness.
💡 Entry Price Zone: Only suitable for speculative entry near 70 ₹ – 75 ₹, closer to DMA support, but not recommended for long-term investors until profitability improves.
📈 Exit Strategy / Holding Period: If already holding, consider exiting near 90 ₹–95 ₹ resistance zone. Long-term holding is risky unless the company turns profitable and efficiency metrics improve significantly.
✅ Positive
- Debt-to-equity ratio of 0.07 indicates low leverage.
- FII holdings increased (+0.29%) and DII holdings increased (+0.45%), showing minor institutional support.
⚠️ Limitation
- Negative EPS (-0.03 ₹) and loss-making status.
- Weak ROE (8.18%) and ROCE (7.45%).
- No dividend yield (0%).
- Stock trading far below 52-week high (Index 38.9%).
📉 Company Negative News
- Quarterly losses widened (PAT -87.6 Cr vs -35.3 Cr).
- Profit variation (-762%) indicates severe earnings volatility.
📈 Company Positive News
- Minor increase in both FII (+0.29%) and DII (+0.45%) holdings.
- Stock trading near DMA levels, showing short-term technical stability.
🏭 Industry
- Industry P/E at 32.0 suggests sector is moderately valued compared to NIVABUPA.
- Insurance sector benefits from rising demand but faces profitability and regulatory challenges.
🔎 Conclusion
NIVABUPA is currently loss-making with weak efficiency metrics, making it unsuitable for long-term investment. Fresh entry should be avoided until profitability improves. Existing holders may consider exiting near resistance levels (90 ₹–95 ₹) while monitoring earnings recovery and operational turnaround.